Blueberries Medical Corp. announced a non-brokered private placement of up to 180,716,000 common shares at a price of CAD 0.011 ($0.0069169304322805) per unit for gross proceeds of up to CAD 1,987,876 ($1,250,000) on December 15, 2023. The Offering is expected to close on or about December 29, 2023.

The Offering will be led by Terraflos Inc and controlled by Facundo Garreton, who serves as the Chairman, CEO, and a director of company.